This work was based on the hypothesis that optimization of growth factor delivery rate and duration, combined with a biomaterial scaffold, could lead to an improved strategy for therapeutic neovascularization. To test this hypothesis, a novel in vivo model system that allows for characterization of stability and mural cell investment of newly created vessels was designed.
|Publisher||University of Cape Town, Faculty of Health Sciences, Department of Surgery|
|Source Sets||South African National ETD Portal|
|Type||Thesis / Dissertation, Doctoral, PhD|
Page generated in 0.0024 seconds